Arkolith/Insider Trading/RANI/Form 4

McKinley Kate

Chief Business OfficerRani Therapeutics Holdings, Inc. (RANI) · full profile →Form 4 · filed Dec 16, 2024
Net Buying
Open-Market Buys
$30K
Open-Market Sells
$0
Net Open-Market Flow
$30K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2024Buy(P)18K$1.67$30K18K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-136787) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML